Tags

Type your tag names separated by a space and hit enter

Topical immunotherapy of alopecia areata. A follow-up study.
Acta Derm Venereol. 1986; 66(3):269-72.AD

Abstract

Ninety-six patients suffering from alopecia areata have been treated with topical immunotherapy. Fifty-one have been treated with dinitrochlorobenzene and 45 with squaric acid dibutylester. Analysis of our group showed that 55 patients out of those 96, who entered the study, experienced hair regrowth during a period of 6-17 weeks of treatment. Of these 55 patients, 25 (45.4%) had a recurrence of AA and 30 (53.6%) had a persistent regrowth during a follow-up of 16 months-6 years. The severity and early development of flare-up and induced allergic contact dermatitis have been the principal factors that have influenced the clinical results.

Authors

Valsecchi R
No affiliation info available
Cainelli T
No affiliation info available
Foiadelli L
No affiliation info available
Rossi A
No affiliation info available

MeSH

Administration, TopicalAdolescentAdultAlopecia AreataChildCyclobutanesDinitrochlorobenzeneFemaleFollow-Up StudiesHumansMaleMiddle AgedNitrobenzenesRecurrence

Pub Type(s)

Journal Article

Language

eng

PubMed ID

2426909

Citation

Valsecchi, R, et al. "Topical Immunotherapy of Alopecia Areata. a Follow-up Study." Acta Dermato-venereologica, vol. 66, no. 3, 1986, pp. 269-72.
Valsecchi R, Cainelli T, Foiadelli L, et al. Topical immunotherapy of alopecia areata. A follow-up study. Acta Derm Venereol. 1986;66(3):269-72.
Valsecchi, R., Cainelli, T., Foiadelli, L., & Rossi, A. (1986). Topical immunotherapy of alopecia areata. A follow-up study. Acta Dermato-venereologica, 66(3), 269-72.
Valsecchi R, et al. Topical Immunotherapy of Alopecia Areata. a Follow-up Study. Acta Derm Venereol. 1986;66(3):269-72. PubMed PMID: 2426909.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Topical immunotherapy of alopecia areata. A follow-up study. AU - Valsecchi,R, AU - Cainelli,T, AU - Foiadelli,L, AU - Rossi,A, PY - 1986/1/1/pubmed PY - 1986/1/1/medline PY - 1986/1/1/entrez SP - 269 EP - 72 JF - Acta dermato-venereologica JO - Acta Derm Venereol VL - 66 IS - 3 N2 - Ninety-six patients suffering from alopecia areata have been treated with topical immunotherapy. Fifty-one have been treated with dinitrochlorobenzene and 45 with squaric acid dibutylester. Analysis of our group showed that 55 patients out of those 96, who entered the study, experienced hair regrowth during a period of 6-17 weeks of treatment. Of these 55 patients, 25 (45.4%) had a recurrence of AA and 30 (53.6%) had a persistent regrowth during a follow-up of 16 months-6 years. The severity and early development of flare-up and induced allergic contact dermatitis have been the principal factors that have influenced the clinical results. SN - 0001-5555 UR - https://www.unboundmedicine.com/medline/citation/2426909/Topical_immunotherapy_of_alopecia_areata__A_follow_up_study_ DB - PRIME DP - Unbound Medicine ER -